Annual Drug Patent Expirations for GADAVIST
Gadavist is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
This drug has twenty-four patent family members in sixteen countries.
The generic ingredient in GADAVIST is gadobutrol. One supplier is listed for this compound. Additional details are available on the gadobutrol profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com